Orlistat is an inhibitor of gastrointestinal lipases, leading to reduced fat absorption.
It is licensed for patients with BMI
> 28 with associated risk factors, a weight management programme should be in place. Use is not recommended
for more than 2 years.
-
Achalasia : Botulinum injections a re m ost e ff ective of all the options f or r elie v ing a lower oeso p hageal sp h i n c...
No comments:
Post a Comment